Ken research has announced in its report, with a percentage share of 20.1% in the total IVD revenues, the biochemistry market in India was the second largest segment in FY'2013. Even though the share of this segment in the overall IVD revenues has declined for the last three fiscal years (FY'2011-FY'2013), the market has grown at a CAGR of 15.7% over FY'2007-FY'2013.
The immunochemistry market has registered revenues of USD 408.8 million in FY'2013. The revenues increased by 40.2% from USD 291.6 million in FY'2012. The highest contribution to these revenues came from the sales of immunochemistry reagents, which along with instruments accounted for 50.5% of the total market in fiscal year 2013.
The biochemistry market in India was dominated by Roche Diagnostics, accounting for a market share of 34.0% in fiscal year 2013. The company has been successful in capturing a major share of the biochemistry market over the years and offers IVD products for laboratories with varying workloads. For instance, Cobas 6000 provides medium workload laboratories with custom-made solutions for clinical chemistry testing, whereas Cobas 4000 is ideal for complete clinical chemistry solution in Laboratories with small workload.
The key topics covered in research included India In-Vitro market size by revenues, immunochemistry market, biochemistry market, hematology market, microbiology market, blood gas and electrolyte market, molecular diagnostic market and so on. The research covered the market trends, growth drivers, market size and constraints.
